Literature DB >> 4223140

Myeloid leukemia C-1498 as a screen for cancer chemotherapeutic agents.

W T Bradner, M H Pindell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4223140

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort.

Authors:  Julien Cobert; Ephraim Hochberg; Nina Woldenberg; Fred Hochberg
Journal:  J Neurooncol       Date:  2009-12-18       Impact factor: 4.130

2.  Histochemical studies on fatty acid in lymphocyte-mediated immune reaction.

Authors:  J Cyong; H Okada
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

3.  Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.

Authors:  Thomas H Corbett; Kathryn White; Lisa Polin; Juiwanna Kushner; Jennifer Paluch; Chuan Shih; Cora Sue Grossman
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

4.  A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model.

Authors:  Alexia Mopin; Virginie Driss; Carine Brinster
Journal:  J Vis Exp       Date:  2016-10-14       Impact factor: 1.355

5.  Acid ceramidase is upregulated in AML and represents a novel therapeutic target.

Authors:  Su-Fern Tan; Xin Liu; Todd E Fox; Brian M Barth; Arati Sharma; Stephen D Turner; Andy Awwad; Alden Dewey; Kenichiro Doi; Barbara Spitzer; Mithun Vinod Shah; Samy A F Morad; Dhimant Desai; Shantu Amin; Junjia Zhu; Jason Liao; Jong Yun; Mark Kester; David F Claxton; Hong-Gang Wang; Myles C Cabot; Edward H Schuchman; Ross L Levine; David J Feith; Thomas P Loughran
Journal:  Oncotarget       Date:  2016-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.